Incidence study with population of Rhone-Alpes region of cancers eligible for hadrontherapy by proton or carbon ions. Description of Tumors and patients characteristics FRESH-PEF2995-en Pascal POMMIER Incidence study with population of Rhone-Alpes region of cancers eligible for hadrontherapy by proton or carbon ions. Description of Tumors and patients characteristics EpiHadron FRESH-PEF2995-en 2995 FRESH-PEF2995 Pascal POMMIER Stéphanie PATIN GROUPEMENT COOPERATION SANITAIRE CENTRE ETOILE Epidemiology France Portal (PEF) GROUPEMENT COOPERATION SANITAIRE CENTRE ETOILE null Pascal;POMMIER hadrontherapy descriptive prospective survey evaluation. Epidemiology incidence ENT Oncology Otolaryngology Healthcare system determinants: Use of care Healthcare system determinants The main objective is to evaluate in the Rhône-Alpes region the incidence of cancers that have an indication eligible for treatment with hadrontherapy by proton or carbon ions. null France Auvergne Rhône-Alpes Individuals Patients population Male Female Infant, Newborn (birth to 28 days) Infant (28 days to 2 years) Child, Preschool (2 to 5 years) Child (6 to 12 years) Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) Type of tumors to identify: A list of the main indications for hadrontherapy by protons and by carbon ions (Appendix 1: list of indications) was developed by experts using data from literature prioritized according to an ""evidence based medicine"" type analysis and based on rendered or expected service criteria (survival and quality of life), (Appendix 2: Literature review method). Criteria for ""patient"" inclusion The study will be carried out with adult and child subjects, with no age limit, who have indications of hadrontherapy, whose dossiers were able to be discussed by experts at a preliminary pluridisciplinary concertation meeting (RCP). Subjects must have a general and psychological condition that is compatible with hadrontherapy (good compliance, possible follow-up, accept to travel where applicable) and absence of co-morbidities that are life-threatening. Criteria for ""tumor"" inclusion The characteristics common to the pathologies to be identified are as follows: Inoperable tumors, which belong to a pathological group recognized as radio-resistant, at the early stage of development (locoregional stage) or recurring or local relapse, with a low metastatic potential or with an M+ dissemination controlled by medical treatments. Tumors: Choroidal melanomas are excluded from the study. Patients: General or psychological condition that is not compatible or threatening co-morbidities. Clinical data Biological data Socio-demographic data Health event/morbidity Health care consumption and services Others Other Through organizations (health services or institutions schools businesses etc.) [500-1000[ individuals Other Observational Study Observational Study 800 Unknown Restricted access Access on specific project only